Relivion Overview

  • Founded

  • 2013

Founded
  • Status

  • Private

  • Employees

  • 28

Employees
  • Latest Deal Type

  • Series A

  • Latest Deal Amount

  • $4.9M

  • Investors

  • 3

Relivion General Information

Description

Developer of a brain neuromodulation device designed to bring relief to patients suffering from chronic neurological and neuropsychiatric disorders. The company's device offers an adaptive and self-learning treatment using a digital therapeutics platform and can be used to treat depression, migraine, and insomnia, enabling patients to have an effective treatment without the risks and costs associated with invasive procedures and without the side effects associated with medications.

Contact Information

Website
www.relivion.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Sderot 12 Giborei Israel
  • Netanya 4250412
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Relivion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 09-May-2018 $4.9M 00.00 000.00 Completed Generating Revenue
1. Seed Round 01-Jan-2015 00.00 00.00 Completed Generating Revenue
To view Relivion’s complete valuation and funding history, request access »

Relivion Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred A1 000,000 00.000000 00.00 00.00 00 00.00 0.000
Preferred A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Relivion’s complete cap table history, request access »

Relivion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a brain neuromodulation device designed to bring relief to patients suffering from chronic neurological and
Therapeutic Devices
Netanya, Israel
28 As of 2022
00.00
00.00 0000-00-00
00000000000 00.00

000000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
00000000000 0000000
Jerusalem, Israel
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Relivion Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Venture Capital-Backed Jerusalem, Israel 00 000.00 00000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Relivion Patents

  • 42

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 6

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Relivion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022546676-A Methods and devices for transcutaneous nerve stimulation therapy Pending 18-Aug-2019 00000000000
US-20220288383-A1 Methods and devices for transdermal neurostimulation treatment Pending 18-Aug-2019 00000000000
EP-4013485-A1 Methods and devices for transdermal neurostimulation treatment Pending 18-Aug-2019 0000000000
JP-2019088894-A Headset for treatment and assessment of medical conditions Active 15-Feb-2019 0
AU-2017249786-A1 Method and device for transdermally applying electrical stimulation to a region of the head having high impedance Active 14-Apr-2016 A61N1/36034
To view Relivion’s complete patent history, request access »

Relivion Executive Team (6)

Name Title Board Seat Contact Info
Shmuel Shany Co-Founder, Co-Chief Executive Officer & President
Scott Drees Co-Chief Executive Officer
Amit Dar Ph.D Co-Founder & Chief Technology Officer
Anthony Borowicz Chief Financial Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Relivion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Relivion Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Champel Capital Venture Capital Minority 000 0000 000000 0
KT Squared Venture Capital Minority 000 0000 000000 0
Terra Venture Partners Venture Capital Minority 000 0000 000000 0
To view Relivion’s complete investors history, request access »

Ready to get started?

Request a free trial